Life Sciences: CDPQ invests in Amplitude

unknown

Caisse de dépôt et placement du Québec (CDPQ) announced an investment in Amplitude, a Québec life sciences fund that finances and supports biotech, medical device and health information technology start-ups. Earlier today, Amplitude announced that it had obtained over 50% of its financing target for its new $200 million fund. CDPQ joins BDC Capital, Fonds de solidarité FTQ, Teralys and Investissement Québec in participating in this first closing. false false false In addition to Amplitude, CDPQ is already active in other life sciences funds such as CTI Life Sciences Fund, Lumira Ventures and Versant Ventures. Transaction details are set out in a news release published by Amplitude. false false false ABOUT CAISSE DE DÉPÔT ET PLACEMENT DU QUÉBEC Caisse de dépôt et placement du Québec (CDPQ) is a long-term institutional investor that manages funds primarily for public and parapublic pension and insurance plans. As at June 30, 2019, it held CA$326.7 billion in net assets. As one of Canada's leading institutional fund managers, CDPQ invests globally in major financial markets, private equity, infrastructure, real estate and private debt. For more information, visit cdpq.com, follow us on Twitter @LaCDPQ or consult our Facebook or LinkedIn pages.